Guggenheim Capital LLC Catalent, Inc. Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

A detailed history of Guggenheim Capital LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 21,416 shares of CTLT stock, worth $1.36 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

21,416

Previous 22,218 3.61%

Holding current value

$1.36 Million

Previous $1.25 Million 3.84%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$56.16 - $60.96 $45,040 - $48,889	-802 Reduced 3.61%	21,416 $1.3 Million
Q2 2024 Aug 14, 2024	BUY	$53.58 - $57.02 $175,528 - $186,797	3,276 Added 17.29%	22,218 $1.25 Million
Q1 2024 May 14, 2024	BUY	$42.56 - $59.82 $166,622 - $234,195	3,915 Added 26.05%	18,942 $1.07 Million
Q4 2023 Feb 14, 2024	BUY	$32.18 - $46.57 $63,877 - $92,441	1,985 Added 15.22%	15,027 $675,000
Q3 2023 Nov 14, 2023	SELL	$44.2 - $50.2 $100,908 - $114,606	-2,283 Reduced 14.9%	13,042 $593,000
Q2 2023 Aug 11, 2023	SELL	$31.86 - $67.26 $27,845 - $58,785	-874 Reduced 5.4%	15,325 $664,000
Q1 2023 May 10, 2023	SELL	$45.44 - $74.26 $246,830 - $403,380	-5,432 Reduced 25.11%	16,199 $1.06 Million
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $7,905 - $15,471	191 Added 0.89%	21,631 $973,000
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $15,412 - $24,090	213 Added 1.0%	21,440 $1.55 Million
Q2 2022 Aug 15, 2022	SELL	$87.2 - $114.05 $881,504 - $1.15 Million	-10,109 Reduced 32.26%	21,227 $2.28 Million
Q1 2022 May 16, 2022	BUY	$94.19 - $124.49 $183,482 - $242,506	1,948 Added 6.63%	31,336 $3.48 Million
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $4.55 Million - $5.29 Million	-38,030 Reduced 56.41%	29,388 $3.76 Million
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $1.29 Million - $1.69 Million	11,853 Added 21.33%	67,418 $8.97 Million
Q2 2021 Aug 13, 2021	BUY	$100.34 - $115.69 $2.38 Million - $2.74 Million	23,700 Added 74.38%	55,565 $6.01 Million
Q1 2021 May 13, 2021	SELL	$101.51 - $125.27 $661,743 - $816,635	-6,519 Reduced 16.98%	31,865 $3.36 Million
Q4 2020 Feb 16, 2021	BUY	$85.88 - $105.36 $1.17 Million - $1.43 Million	13,606 Added 54.91%	38,384 $3.99 Million
Q3 2020 Nov 13, 2020	BUY	$72.74 - $92.5 $217,347 - $276,390	2,988 Added 13.71%	24,778 $2.12 Million
Q2 2020 Aug 14, 2020	BUY	$48.02 - $79.04 $71,021 - $116,900	1,479 Added 7.28%	21,790 $1.6 Million
Q1 2020 Jun 02, 2020	SELL	$36.95 - $62.95 $62,002 - $105,630	-1,678 Reduced 7.63%	20,311 $1.06 Million
Q4 2019 Feb 14, 2020	BUY	$47.06 - $56.64 $163,015 - $196,200	3,464 Added 18.7%	21,989 $1.24 Million
Q3 2019 Nov 14, 2019	BUY	$47.45 - $58.05 $9,347 - $11,435	197 Added 1.07%	18,525 $883,000
Q2 2019 Aug 14, 2019	BUY	$39.26 - $54.21 $119,978 - $165,665	3,056 Added 20.01%	18,328 $993,000
Q1 2019 May 15, 2019	SELL	$29.84 - $43.92 $388,069 - $571,179	-13,005 Reduced 45.99%	15,272 $620,000
Q4 2018 Feb 14, 2019	SELL	$29.95 - $46.34 $296,954 - $459,461	-9,915 Reduced 25.96%	28,277 $882,000
Q3 2018 Nov 14, 2018	SELL	$40.12 - $45.55 $654,758 - $743,376	-16,320 Reduced 29.94%	38,192 $1.74 Million
Q2 2018 Aug 14, 2018	SELL	$38.72 - $42.52 $8.69 Million - $9.54 Million	-224,406 Reduced 80.46%	54,512 $2.28 Million
Q1 2018 May 15, 2018	SELL	$39.4 - $47.39 $388,878 - $467,739	-9,870 Reduced 3.42%	278,918 $11.5 Million
Q4 2017 Feb 14, 2018	BUY	$37.27 - $43.02 $8.43 Million - $9.73 Million	226,122 Added 360.84%	288,788 $11.9 Million
Q3 2017 Nov 14, 2017	BUY	$33.75 - $41.67 $2.11 Million - $2.61 Million	62,666	62,666 $2.5 Million

Others Institutions Holding CTLT

# of Institutions

514

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Catalent, Inc. Transaction History